Verizon Chairman and CEO Hans Vestberg delivers kick-off keynote at 2021 Consumer Electronics Show

Showcases impact of Verizon 5G across industries with the NFL,

the Metropolitan Museum of Art, the Smithsonian, UPS, Live Nation Clubs and Theaters and more

Video replay and highlights can be found at

https://www.verizon.com/about/ces-2021

BASKING RIDGE, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) — Today, Verizon Chairman and Chief Executive Officer Hans Vestberg took to the virtual Consumer Electronics Show (CES) stage to deliver the 2021 kick-off keynote address. This marked his second appearance on the CES keynote stage in two years. In 2019, Vestberg promised that Verizon’s 5G would usher in the “Fourth Industrial Revolution.” And today, he brought the impact 5G is having to life through compelling present-day 5G use cases across sports, education, connected communities and live music.

“Our world has experienced significant change since we last took the keynote stage at CES in 2019. There’s been an extreme acceleration in the digital revolution, and at the heart of that transformation is 5G technology. The future of work, learning, telehealth, retail and streaming are very much our current realities. And we are just getting started. 5G isn’t just another tech innovation, it’s the platform that makes other innovations possible.” — Hans Vestberg, Chairman and CEO, Verizon.

During the presentation, Verizon made announcements with several partners including the NFL, UPS, Live Nation Clubs and Theaters, The Met and the Smithsonian. Details on these announcements can be found below.

Featured partners and announcements:


Changing the Game


Partner: NFL
Guests: Roger Goodell, NFL Commissioner and Deion Sanders, NFL legend and head football coach at Jackson State University
News: Verizon commits to 5G Ultra Wideband in 28 NFL stadiums by the end of 2021 with expanded coverage in select stadiums.

NFL Commissioner Roger Goodell and Deion Sanders, NFL Legend and head football coach at Jackson State University, joined Verizon’s CES stage today to discuss how 5G is changing the fan experience by delivering immersive ways to watch and engage with the game. Verizon’s 5G SuperStadium in the NFL app allows fans with certain 5G-enabled devices to engage with select games with up to seven different camera angles, bringing them closer to the on-field action. Augmented reality (AR) overlays let fans project virtual players and layers the NFL’s Next Gen Stats proprietary tracking data on-screen with enhanced games stats for players during each play.

Verizon also confirmed availability of 5G Ultra Wideband in Raymond James Stadium, home of Super Bowl LV, and announced 5G Ultra Wideband will be live in 28 NFL stadiums in 2021 with expanded coverage in select stadiums.


Next Era of Immersive Learning


Partner: Smithsonian
News: Verizon is building upon our use of the Smithsonian’s Open Access platform to bring even more 3D artifacts into augmented reality.
Guest: Secretary Lonnie Bunch, Smithsonian Institution

Verizon announced an expansion of its relationship with the Smithsonian by supporting its upcoming “Race, Community, and Our Shared Future” Initiative. Over the next five years, Verizon will provide high fidelity scanning of collections and artifacts along with the creation of new digital experiences that bring history and culture to life regardless of where the viewer is.

Verizon has been an early innovator with Smithsonian’s Open Access platform helping to bring existing 3D artifacts into augmented reality, like the Apollo 11 Columbia Command module. Now as part of the Smithsonian’s efforts to broaden access to diverse collections, a few never-before-released AR artifacts will soon be launched, including objects from two exhibitions at the National Museum of American History: Girlhood (It’s Complicated) which explores girlhood in the U.S. and how girls changed history in politics, education, work, health, and fashion and ¡Pleibol! In the Barrios and the Big Leagues / En los barrios y las grandes ligas which shows how Latino communities played, celebrated and changed the game of baseball. With Verizon’s support, the high fidelity of these artifacts allows the learner to experience the object up close, while hearing from museum curators the stories that contextualize their cultural significance.

Partner: The Metropolitan Museum of Art
News: The Metropolitan Museum of Art and Verizon Launch Interactive Virtual Art Experience
Press Release: https://www.verizon.com/about/news/metropolitan-museum-art-verizon-virtual-art-experience

The Metropolitan Museum of Art and Verizon today launched The Met Unframed, an immersive virtual art and gaming experience, with enhancements available to those connected by Verizon 5G Ultra Wideband, that features more than a dozen one-of-a-kind digitally rendered galleries and nearly 50 works of art from across The Met’s vast collection. At a time when access to one of the world’s greatest art collections is limited, The Met Unframed brings a creatively reimagined Met experience to people wherever they are.


TheMetUnframed.com
invites online visitors to explore digital galleries and play games that unlock augmented reality (AR) versions of the art on view that can then be displayed virtually at home. The Met Unframed is accessible from any 4G or 5G smart device, and is available for free for a limited five-week run. Within the experience, four of the AR works of art are enhanced with activations accessible to users on Verizon 5G Ultra Wideband. These users can watch the objects come alive in AR by utilizing high-speed responsiveness and ultra low lag.


Building the New Smart City


Partner: UPS & Skyward
News: Verizon, UPS, and Skyward announce connected drone delivery
Guest: Carol B. Tomé, CEO, UPS and Mariah Scott, President, Skyward, A Verizon Company
Press Release: https://www.verizon.com/about/news/verizon-ups-skyward-drone-delivery-ces-2021

Skyward, a Verizon company, and UPS Flight Forward announced collaborative efforts to deliver retail products with drones connected to Verizon 4G LTE, as well as 5G testing and integration for delivery. The companies aim to deliver retail products via connected drones at The Villages in Florida.

In 2020, Verizon, UPS Flight Forward, and Skyward started testing 4G LTE in delivery drones to demonstrate cellular reliability and performance at altitude.

For a busy logistics hub that includes fleets of drones, trucks, and planes, the low latency of 5G Ultra Wideband and edge compute is ideal for monitoring traffic and freight locations. With the rise of autonomous aerial and ground vehicles, 5G will be essential.

UPS has operated more than 3,800 successful flights for drone delivery since the creation of UPS Flight Forward, its drone delivery company, certified by the Federal Aviation Administration in 2019. But in 2020, drone delivery emerged as much more than rapid delivery of essential healthcare items — during the global pandemic it provided high-risk seniors a rapid and contactless delivery option to remain healthy at home.


The 5G Age of Entertainment


Partner: Live Nation Clubs and Theaters
News: Verizon has partnered with 15 iconic Live Nation Clubs and Theaters to deploy 5G Ultra Wideband across the country, including The Wiltern in Los Angeles, The Fillmore in Miami, The Masonic Theater in San Francisco and Irving Plaza in New York.
Guest: Black Pumas

Verizon has partnered with 15 iconic Live Nation Clubs and Theaters to deploy 5G Ultra Wideband across the country, giving audiences new ways of experiencing music both in person and virtually. 5G’s capacity and speed will provide access to multiple camera angles for fans to enjoy live streams of shows as if they were seated in the front row, while also powering new tools being developed to manage crowd flow and more in-venue elements.

The Wiltern in Los Angeles is the first 5G Ultra Wideband-enabled music club. Today, CES attendees were given a sneak peek of a special performance by 4-time Grammy Award nominees Black Pumas at The Wiltern featuring their hit singles “Colors” and “Fire,” which included a multi-cam viewing and a 360-degree portal experience. The full concert will be available to members of Verizon’s loyalty program, Verizon Up. More details will be announced at a later date. The Fillmore in Miami, The Masonic Theater in San Francisco and Irving Plaza in New York City are some of the venues that will integrate 5G Ultra Wideband. Additional clubs and theaters will be announced at a later date.

About Verizon:
Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed on June 30, 2000 and is celebrating its 20th year as one of the world’s leading providers of technology, communications, information and entertainment products and services. Headquartered in New York City and with a presence around the world, Verizon generated revenues of $131.9 billion in 2019. The company offers data, video and voice services and solutions on its award-winning networks and platforms, delivering on customers’ demand for mobility, reliable network connectivity, security and control.

VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at https://www.verizon.com/about/media-center. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.

Media contact:

Lauren Tilstra
[email protected]
908-635-9099

Jason Shumaker
[email protected]
917-747-5155



Barnwell Industries, Inc. Reports Receipt of Notice of Nominations and Formation of Special Committee; Provides Business Update

HONOLULU, Jan. 11, 2021 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE American: BRN) (“Barnwell”, the “Company”) announced today that it has received notice of director nominations for election at the 2021 annual meeting of stockholders (the “2021 Annual Meeting”) from Ned L. Sherwood, Bradley M. Tirpak and MRMP-Managers LLC, who also jointly nominated directors for election at Barnwell’s 2020 annual meeting of stockholders.

Mr. Alexander C. Kinzler, Chief Executive Officer and President, commented, “In response to the receipt of notice, the Barnwell Board has created a special committee comprised of Peter J. O’Malley, chairman, Kenneth S. Grossman and Robert J. Inglima, Jr., each of whom is an independent director, for the purpose of considering various matters relating to the potential of another proxy contest initiated by Messrs. Sherwood, Tirpak and MRMP-Managers LLC in connection with the 2021 Annual Meeting. The Company intends to provide updates if and when necessary, in accordance with applicable securities laws.”

Mr. O’Malley, chairman of the special committee, commented that “While it is unfortunate that the stockholder group has commenced an election contest for the second year in a row, the special committee intends to engage with the stockholder group to see if a costly and disruptive fight can be avoided so that the Barnwell Board can remain focused on enhancing value for stockholders.”

Separately, the Company announced that two additional developer lots closed in December 2020 at Kaupulehu, North Kona, Hawaii, in consideration for which the Company’s Kaupulehu Developments venture received $485,000 in percentage of sales payments ($320,000 net to the Company) and the Company received cash distributions of $1,712,000, which includes an additional preferred return payment of $459,000. These transactions will be reflected in the Company’s financials for the quarter ended December 31, 2020.

About Barnwell Industries, Inc.

Barnwell Industries, Inc. and its subsidiaries are principally engaged in oil and natural gas exploration, development, production and sales in Canada; investing in leasehold interests in real estate in Hawaii; and well drilling services and water pumping system installation and repairs in Hawaii.

Additional Information

Barnwell intends to file a proxy statement and WHITE proxy card with the U.S. Securities and Exchange Commission (the “SEC”) in connection with its solicitation of proxies for its 2021 Annual Meeting. Details concerning the nominees of Barnwell’s Board of Directors for election at the 2021 Annual Meeting will be included in the proxy statement. BARNWELL STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY STATEMENT (AND ANY AMENDMENTS AND SUPPLEMENTS THERETO) AND ACCOMPANYING WHITE PROXY CARD WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders may obtain the proxy statement, any amendments or supplements to the proxy statement and other documents as and when filed by Barnwell with the SEC without charge from the SEC’s website at www.sec.gov or by contacting Morrow Sodali LLC, Barnwell’s proxy solicitor, at:

(800) 662-5200 (toll-free in North America)
+1 (203) 658-9400 (outside of North America)
[email protected]

Certain Information Regarding Participants

Barnwell, its directors and certain of its executive officers may be deemed to be participants in connection with the solicitation of proxies from Barnwell’s stockholders in connection with the matters to be considered at the 2021 Annual Meeting. Information regarding the ownership of Barnwell’s directors and executive officers in Barnwell stock is included in their SEC filings on Forms 3, 4, and 5, which can be found through the SEC’s website at www.sec.gov. Information can also be found in Barnwell’s other SEC filings. More detailed and updated information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement and other materials to be filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

Safe Harbor for Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Exchange Act. These forward-looking statements are predictions and generally can be identified by use of statements that include phrases such as “plan,” “expect,” “will,” “should,” “could,” “anticipate,” “intend,” “project,” “estimate,” “guidance,” “possible,” “continue” and other similar terms and phrases, including references to assumptions and forecasts of future results. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results to differ materially from those anticipated at the time the forward-looking statements are made. These risks include, but are not limited to, those described in “Risk Factors” and elsewhere in the Company’s Annual Report on Form 10-K for the year ended September 30, 2020 and subsequent filings with the SEC. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. No assurance can be given that the future results covered by the forward-looking statements will be achieved. All forward-looking statements contained in this release are qualified by these cautionary statements and are made only as of the date of this release. The Company does not undertake any obligation to update or revise these forward-looking statements except as required by law.

CONTACT: Alexander C. Kinzler
Chief Executive Officer and President
   
  Russell M. Gifford
Executive Vice President and Chief Financial Officer
Tel: (808) 531-8400



CORRECTION – PyroGenesis Announces Guidance for Q4 2020

MONTREAL, Jan. 11, 2021 (GLOBE NEWSWIRE) —  In a release issued under the same headline on Monday, January 11th by PyroGenesis Canada Inc. (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), please note that the numerical values in the table under Guidance 2020, Revenue, Q4 and YE have been corrected to $3-5 MM and $14-16 MM respectively. The corrected release follows:

PyroGenesis Canada Inc. (http://www.pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to provide guidance for the fourth quarter, and full year, both ending December 31st, 2020.

Based on preliminary financial information, and subject to year-end closing adjustments, PyroGenesis expects revenue for the fourth quarter 2020 to be between $3 – $5 million, resulting in total revenues for the fiscal year ending 2020 of approximately $14 – $16 million, as compared to $1.07 million (Q4 2019) and $4.8 million (FY 2019), respectively.

The Company also expects earnings per share (“EPS”) for the fourth quarter to be in the range of $0.10 – $0.12, and for the fiscal year ending 2020 of between $0.22 – $0.24 , as compared to a loss of $0.04 (Q4 2019) and a loss of $0.07 (FY2019), respectively.

The Q4 2020 guidance and actual 2019 results noted above are summarized in the following table below:

  Actual 2019 Guidance 2020
Revenue    
Q4 $1.07 MM $3-5 MM
YE $4.8 MM $14-16 MM
EPS Basic    
Q4 ($0.04) $0.10-$0.12
YE ($0.07) $0.22-$0.24

About PyroGenesis Canada
Inc.

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at


www.sedar.com
,

or at


www.otcmarkets.com
. 

Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:

Rodayna Kafal, Vice President, IR/Comms. and Strategic BD
Phone: (514) 937-0002, E-mail: [email protected] 

RELATED LINK: http://www.pyrogenesis.com/ 



Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against QuantumScape Corporation – QS

RADNOR, Pa., Jan. 11, 2021 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against QuantumScape Corporation (NYSE:  QS) (“QuantumScape”) on behalf of those who purchased or otherwise acquired QuantumScape publicly traded securities between November 27, 2020 and December 31, 2020, inclusive (the “Class Period”).


Investors who purchased or acquired QuantumScape publicly traded securities


during the Class Period may, no later than March 8, 2021, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP (James Maro, Esq. (484-270-1413) or Adrienne Bell, Esq. (484-270-1435)); toll free at (844) 887-9500; via e-mail at


[email protected]
; orclick https://www.ktmc.com/quantumscape-corporation-securities-class-action?utm_source=PR&utm_medium=link&utm_campaign=qunatumscape#overview

According to the complaint, QuantumScape develops and commercializes solid-state lithium-metal batteries for electric vehicles (“EVs”). In 2012, QuantumScape began working with Volkswagen Group of America, Inc. (“Volkswagen”) and Volkswagen Group of America Investments, LLC (“VGA”) to develop an EV battery. In 2018, Volkswagen, VGA and QuantumScape announced the establishment of a joint production project to prepare solid-state batteries for mass production. On September 3, 2020, QuantumScape announced a merger with Kensington. Upon completion of the transaction, QuantumScape would receive $1 billion in financing, including funding from VGA and the Qatar Investment Authority.  That transaction was completed on November 27, 2020, and QuantumScape Class A common stock and warrants began trading on the NYSE.

On January 4, 2021, prior to the open of trading, Seeking Alpha published a research report entitled “QuantumScape’s Solid State Batteries Have Significant Technical Hurdles To Overcome.” The introduction of the Seeking Alpha report emphasized that “QuantumScape’s science is very good,” “[b]ut their batteries are small and unproven – not yet as big as an iWatch battery, and never tested outside a lab,” adding that “[t]here are significant risks associated with solid state batteries that have not been overcome,” and emphasizing that “[t]hey will likely never achieve the performance they claim.”

Following this news, the market prices of QuantumScape publicly traded securities fell precipitously, with the price of QuantumScape’s Class A common stock declining more than 63% from its Class Period high of more than $131 per share on December 22, 2020 to close down at $49.96 per share on January 4, 2021, including a one-day decline of more than $34 per share, or 41%, on January 4, 2021.

The complaint alleges that, throughout the Class Period, the defendants misrepresented and/or failed to disclose to investors that: (a) QuantumScape’s battery technology was not sufficient for EV performance as it would not be able to withstand the aggressive automotive environment; (b) QuantumScape’s battery technology likely provided no meaningful improvement over existing battery technology; (c) the successful commercialization of QuantumScape’s battery technology was subject to much more significant risks and uncertainties than the defendants had disclosed; and (d) as a result of the foregoing, the defendants materially overstated the value and prospects of QuantumScape’s battery technology.

QuantumScape investors who wish to discuss this securities fraud class action lawsuit and their legal options are encouraged to contact Kessler Topaz Meltzer & Check, LLP (James Maro, Jr., Esq. or Adrienne Bell, Esq.) at (844) 887-9500 (toll free) or at [email protected].

QuantumScape investors may, no later than March 8, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member.  A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class.  Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP, prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.  The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).  The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
(610) 667-7706
[email protected]



Mount Logan Capital Inc. Provides Update on Investment Portfolio and Leverage Facility

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

All figures in United States dollars unless otherwise noted.

TORONTO, Jan. 11, 2021 (GLOBE NEWSWIRE) — Mount Logan Capital Inc. (NEO: MLC) (“Mount Logan” or the “Company”) is pleased to announce that it has divested a substantial portion of its loan portfolio above its most recently disclosed aggregate fair market value. The Company sold its entire ownership interest of the First Lien Term Loans of SW Ingredients Holdings, LLC, Welcome Dairy, LLC, Arcline FM Holdings LLC, TCP Sunbelt Acquisition Co. and Wesco Group, LLC at a weighted average price of 98.04% of face value (compared with a weighted average fair market value of 97.17% of face value as of September 30, 2020) for aggregate cash proceeds of approximately $15,876,721. In connection with the sale of this portfolio of loans, the Company’s wholly-owned subsidiary, Great Lakes Senior MLC I LLC, (“Great Lakes”) notified its lender under the $50 million revolving senior loan facility (the “Leverage Facility”) that it intends to repay the then outstanding balance and terminate the Leverage Facility on or before its maturity date of February 19, 2021.

Ted Goldthorpe, CEO and Chairman of Mount Logan, noted, “Our leverage facility and lending partner were critical in enhancing our portfolio yields during the first phase of Mount Logan’s business plan; however, the divestment of a number of illiquid loans and wind down of our Leverage Facility accelerates Mount Logan’s transition to an asset light business model with less leverage. Furthermore, the sale of these illiquid First Lien Term Loans near par illustrates the strength of our investment portfolio and the quality of Mount Logan’s net asset value.”

About Mount Logan Capital Inc.

Mount Logan Capital Inc. is an alternative asset management company that is focused on public and private debt securities in the North American market. The Company seeks to source and actively manage loans and other debt-like securities with credit-oriented characteristics. The Company actively sources, evaluates, underwrites, monitors and primarily invests in loans, debt securities, and other credit-oriented instruments that present attractive risk-adjusted returns and present low risk of principal impairment through the credit cycle.

Cautionary Notes

This press release contains forward-looking statements and information within the meaning of applicable securities legislation (collectively referred to herein as “

forward-looking statements

”). Forward-looking statements can be identified by the expressions “seeks”, “expects”, “believes”, “estimates”, “will”, “target” and similar expressions. The forward-looking statements are not historical facts, but reflect the current expectations of management of the Company regarding future results or events and are based on information currently available to them. Certain material factors and assumptions were applied in providing these forward-looking statements. The forward-looking statements discussed in this
press release may include, but are not limited to, statements relating to the Company’s transition to an asset-light business model, Great Lakes’ plans to repay the outstanding balance under the Leverage Facility and terminate the Leverage Facility at maturity and statements relating to the business and future activities of the Company. All forward-looking statements in this press release are qualified by these cautionary statements. The Company believes that the expectations reflected in forward-looking statements are reasonable based on upon the information available at the time such information was given; however, the Company can give no assurance that the actual results or developments will be realized by certain specified dates or at all. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations, including the risk that Great Lakes’ plans to repay and terminate the Leverage Facility at maturity may change and, if so, there are no assurances that the Company or Great Lakes will be able to renew the Leverage Facility on terms acceptable to the Company and Great Lakes or at all, the Company has a limited operating history with respect to an asset-light business model
as well as
the matters discussed under “Risk Factors” in the most recently filed annual information form and management’s discussion and analysis for the Company. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. The Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances except as required by securities laws. The forward-looking statements in this press release are made as of the date of this press release.

This press release is not, and under no circumstances is it to be construed as, a prospectus or an advertisement, and the communication of this press release is not, and under no circumstances is it to be construed as, an offer to sell or a solicitation of an offer to purchase securities of the Company. This press release is not intended for U.S. persons. The Company’s shares are not and will not be registered under the U.S. Securities Act of 1933, as amended, and the Company is not and will not be registered under the U.S. Investment Company Act of 1940 Act (the “1940 Act”). U.S. persons are not permitted to purchase the Company’s shares absent an applicable exemption from registration under each of these Acts. In addition, the number of investors in the United States, or which are U.S. persons or purchasing for the account or benefit of U.S. persons, will be limited to such number as is required to comply with an available exemption from the registration requirements of the 1940 Act.

For additional information, please contact:

Ted Gilpin, Chief Financial Officer
[email protected]



ROSEN, TOP RANKED GLOBAL COUNSEL, Reminds JOYY Inc. Investors of Important January 19 Deadline in Securities Class Action First Filed by the Firm – YY

ROSEN, TOP RANKED GLOBAL COUNSEL, Reminds JOYY Inc. Investors of Important January 19 Deadline in Securities Class Action First Filed by the Firm – YY

NEW YORK–(BUSINESS WIRE)–
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of JOYY Inc. (NASDAQ: YY) between April 28, 2016 and November 18, 2020, inclusive (the “Class Period”), of the important January 19, 2021 lead plaintiff deadline in the first filed securities class action lawsuit commenced by the firm. The lawsuit seeks to recover damages for JOYY investors under the federal securities laws.

To join the JOYY class action, go to http://www.rosenlegal.com/cases-register-1988.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) the majority of users at any given time were bots; (3) JOYY utilized these bots to effect a roundtripping scheme that manufactured the false appearance of revenues; (4) JOYY overstated its cash reserves; (5) JOYY’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (6) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 19, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1988.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – GDRX

NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the “Class Period”), of the important February 16, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoodRx investors under the federal securities laws.

To join the GoodRx class action, go to http://www.rosenlegal.com/cases-register-2011.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

The GoodRx class action lawsuit alleges that, at the time of the Company’s initial public offering (“IPO”), unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. According to the GoodRx class action lawsuit, given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, their statements in the Registration Statement and during the Class Period about GoodRx’s competitive position were materially false and/or misleading when made and caused GoodRx Class A common stock to trade at artificially inflated prices of more than $64 per share during the Class Period.

Then on November 17, 2020, just weeks after GoodRx completed its IPO, Amazon announced two new pharmacy offerings, a Prime Rx plan and a discount card program, which, among other things, would compete directly with GoodRx’s platform by making it “simple for customers to compare prices and purchase medications for home delivery, all in one place.” In response to this news, the price of GoodRx Class A common stock declined 23%, from $46.72 per share to $36.21 per share by market close on November 17, 2020, damaging investors.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 16, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-2011.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        [email protected]
        [email protected]
        www.rosenlegal.com



Theratechnologies Announces US$40 Million Bought-Deal Public Offering of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Theratechnologies Announces US$40 Million Bought-Deal Public Offering of Units

Montreal, QC , Jan. 11, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX) ), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it has entered into an agreement with Mackie Research Capital Corporation as the lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters, including Canaccord Genuity Corp. and National Bank Financial Inc. (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought-deal basis, 14,546,000 units of the Company (the “Units”) for aggregate gross proceeds to the Company of US$40,001,500 (equivalent to approximately C$51,081,915) (the “Offering“) at a price of US$2.75 per Unit (equivalent to approximately C$3.51 per Unit).

Each Unit shall be comprised of one common share of the Company (each a “Common Share“) and one-half of one Common Share purchase warrant of the Company (each whole warrant, a “Warrant“). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of US$3.18 (equivalent to approximately C$4.06) at any time up to 36 months from the closing of the Offering.

The Company has granted to the Underwriters an option (the “Over-Allotment Option”) to increase the size of the Offering by up to an additional number of Units, and/or the components thereof, that in aggregate would be equal to 15% of the total number of Units to be issued under the Offering, to cover over-allotments, if any, and for market stabilization purposes, exercisable at any time and from time to time up to 30 days following the closing of the Offering.

The net proceeds from the Offering will be used primarily to fund research and development activities, commercialisation initiatives, general and administrative expenses, working capital needs and other general corporate purposes.

The closing of the Offering is expected to occur on or about January 19, 2021 (the “Closing”) and is subject to the Company receiving all necessary regulatory approvals, including the approval of the Toronto Stock Exchange (the “TSX”) to list, on the date of Closing, the Common Shares and the Common Shares issuable upon exercise of the Warrants thereon.  The Company agreed to use its commercial reasonable efforts to list the Warrants on the TSX on the date of Closing.

In connection with the Offering, the Company intends to file a prospectus supplement to the Company’s short form base shelf prospectus dated November 15, 2019, with the securities regulatory authorities in each of the provinces of Canada. Copies of the base shelf prospectus and, any supplement thereto to be filed in connection with the Offering, can be found on SEDAR at www.sedar.com.

This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company’s website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

Forward-Looking Information

This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management’s beliefs and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as “may”, “will”, “should”, “could”, “would”, “outlook”, “believe”, “plan”, “envisage”, “anticipate”, “expect” and “estimate”, or the negatives of these terms, or variations of them. The forward-looking statements contained in this press release include, but are not limited to, statements regarding the offer and sale of Units, the use of proceeds from the Offering, the exercise by the Underwriters of the Over-Allotment Option, the timing regarding the closing date of the Offering, and the listing of the Common Shares and Warrants on the TSX.

Forward-looking statements are based upon a number of assumptions and include, but are not limited to, the following: the Covid-19 pandemic will have limited adverse effect on the Offering and the timelines to close the Offering, the proceeds from the Offering will be allocated for the activities set forth herein and we will have enough funds to carry out our business plan.

Forward-looking statements are subject to a variety of risks and uncertainties, many of which are beyond our control that could cause our actual results to differ materially from those that are disclosed in or implied by the forward-looking statements contained in this press release. These risks and uncertainties include, among others, the risk that the Offering does not close as a result of certain events triggering the right of the Underwriters to exercise their market out provisions, the TSX not listing the additional Common Shares to be issued under the Offering, a resurgence in the Covid-19 pandemic adversely affecting our activities and those of our suppliers and third-party service providers and the discovery of unwanted adverse side effects from the long-term use of our products leading to a withdrawal or recall of our products.

We refer potential investors to the “Risk Factors” section of our annual information form dated February 24, 2020 available on SEDAR at www.sedar.com and on EDGAR at www.sec.gov as an exhibit to our report on Form 40-F dated February 25, 2020 under Theratechnologies’ public filings for additional risks regarding the conduct of our business and Theratechnologies. The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward-looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date.

We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise, except as may be required by applicable law.

For Media Inquiries:

Denis Boucher
Vice President, Communications and Corporate Affairs
[email protected]
514-336-7800

For Investor Inquiries:

Leah Gibson
Senior Director, Investor Relations
[email protected]
617-356-1009



US Lighting Group and Intellitronix Corporation Finish 2020 on a Positive Note

EUCLID, Ohio, Jan. 11, 2021 (GLOBE NEWSWIRE) — U.S. Lighting Group, Inc. (OTC:USLG) and, its wholly owned subsidiary, Intellitronix Corporation, experienced a record-breaking year in sales, products manufactured, and products shipped in 2020. In the opinion of the company’s management, the US Lighting Group will be profitable anticipating approximately $4 million in gross sales, an estimated $1.4 million or 50% increase over 2019.

“The US Lighting Group had an outstanding year in 2020 with roughly $4 million dollars in gross sales. We surpassed prior year records with products shipped out the door in Q3 and Q4. Many businesses experienced a downturn during the COVID-19 global pandemic, but we were very fortunate to have the opposite occur. At one point, we had a backlog of orders valued over $900,000. To strengthen our production process, we purchased a new Speed Print Technology 700 Series screen printer and high speed Europlacer iineo+ SMT Component Placement System, increasing our printed circuit board (PCB) output three-fold.” said Paul Spivak, CEO of the US Lighting Group.

The US Lighting Group is a US designer and manufacturer of commercial LED lighting products, automotive and patented marine electronics, groundbreaking energy management products for the RV industry. The company plans to expand the company portfolio to manufacture recreational vehicles for the RV Market. cortescampers.com

About U.S. Lighting Group, Inc. and Intellitronix Corp

US Lighting Group (OTC:USLG) and its wholly owned subsidiary, Intellitronix Corporation, are leading manufacturers of electronics, supplying growth sectors such as LED lighting, custom designed LED products, microprocessor-controlled LED instrumentation, custom private labeled electronics, automotive, RV, and marine electronics. The company has manufacturing and R&D facilities in Cleveland, Ohio with an international sales distribution network. uslightinggroup.com

Forward-Looking Statements

Statements included in this press release, other than statements of historical fact, are forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are typically, but not always, identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements.

Contact
US Lighting Group
1148 East 222nd Street
Euclid, OH 44117 USA
T: +1 216.896.7000
[email protected]



Cybin Announces API Synthesis of Multiple Tryptamine Derivatives Based on the First Milestone Achievement Pursuant to the Adelia Acquisition

Cybin Announces API Synthesis of Multiple Tryptamine Derivatives Based on the First Milestone Achievement Pursuant to the Adelia Acquisition

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (“Cybin” or the “Company”), a life sciences company focused on psychedelic therapeutics, is pleased to announce that Adelia Therapeutics Inc. (“Adelia”), a wholly-controlled subsidiary of Cybin, has achieved the earn-out milestones for the period commencing November 15, 2020, as contemplated by the terms of a contribution agreement dated December 4, 2020 (the “Transaction Agreement”) among Cybin, Cybin Corp., Cybin US Holdings Inc. (“Acquiror”), a wholly-controlled subsidiary of Cybin, and all of the previous shareholders of Adelia (the “Adelia Shareholders”).

The achievement includes the successful synthesis of multiple tryptamine derivatives in sufficient quantities to initiate in vitro “Proof of Principle”; establish a ADME/PK has been completed; and to demonstrate “In Vitro” ADME “Proof of Principle” that specific synthesis modifies the metabolism of a psychedelic tryptamine.

Pursuant to the terms of the Transaction Agreement, an aggregate of 51,163.1 Class B common shares in the capital of the Acquiror (the “Class B Shares”) shall be issued to the Adelia Shareholders in satisfaction of the CDN$1,018,145.43 (approximately US$803,418.56) due to them on meeting the relevant milestone. The Class B Shares issued by the Acquiror to the Adelia Shareholders are exchangeable for common shares in the capital of Cybin (the “Cybin Shares”) on a 10 Cybin Shares for 1 Class B Share basis, at the option of the holder thereof, subject to customary adjustments. No Class B Shares are exchangeable prior to the first anniversary of closing of the contribution transaction pursuant the Transaction Agreement (the “Transaction”), which closed on December 14, 2020, and not more than: (i) 33 1/3% of the Class B Shares will be exchangeable prior to the second anniversary of the Transaction; (ii) 66 2/3% of the Class B Shares will be exchangeable prior to the third anniversary of the Transaction; and (iii) thereafter, 100% of the Class B Shares will be exchangeable.The Class B Shares issued to the Adelia Shareholders are exchangeable for a total of 511,631 Cybin Shares, resulting in an effective issue price of CDN$1.99 per Cybin Share.

Additional information related to the Transaction is available in the Transaction Agreement, which is filed under Cybin’s profile on SEDAR (www.sedar.com).

About Cybin Inc.

Cybin is a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions. Cybin is developing technologies and delivery systems, aiming to improve bioavailability, to potentially achieve the desired medicinal effects of psychedelics at low dosage levels. The new delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About Adelia

Adelia is a company that aims to develop medicinal psychedelics with improved dosing efficacy and therapeutic indices to address unmet medical needs. Adelia’s primary focus is on the development of treatment regimens consisting of proprietary psychedelic molecules and related clinical protocols. This proprietary development strategy is based on chemical modifications to the known and well understood tryptamine derivatives that significantly modify their pharmacokinetic properties without changing their therapeutic potential. These proprietary approaches seek to minimize inter-patient variability by better controlling drug metabolism without loss of efficacy that together have been shown to produce more predictable and favorable patient outcomes.

Cautionary Notes and Forward Looking Statements

Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding Cybin’s future, strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only Cybin’s expectations, estimates and projections regarding future events. These statements are not guaranteeing future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. The forward-looking information and forward-looking statements included in this press release are made as of the date of this press release. The Company does not undertake an obligation to update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities law. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date.

Cybin makes no medical, treatment or health benefit claims about Cybin’s proposed products. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds or nutraceutical products. The efficacy of such products have not been confirmed by approved research. There is no assurance that the use of psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds or nutraceuticals can diagnose, treat, cure or prevent any disease or condition. Vigorous scientific research and clinical trials are needed. Cybin has not conducted clinical trials for the use of its proposed products. Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials. If Cybin cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on Cybin’s performance and operations.

The NEO Exchange has not approved or disapproved the contents of this news release.

Investor Contacts:

Tim Regan/Scott Eckstein

KCSA Strategic Communications

[email protected]

Lisa M. Wilson

In-Site Communications, Inc.

[email protected]

Media Liaisons:

Jackie Poriadjian

Chief Marketing Officer, Cybin

[email protected]

KEYWORDS: United States North America Canada

INDUSTRY KEYWORDS: Biotechnology Health Science Pharmaceutical Research

MEDIA:

Logo
Logo